Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

CUSIP: 230031106

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
59,091,689
Total 13F shares
36,858,851
Share change
+2,306,702
Total reported value
$375,589,972
Put/Call ratio
90%
Price per share
$10.19
Number of holders
110
Value change
+$26,958,804
Number of buys
66
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q4 2023

As of 31 Dec 2023, Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,858,851 shares. The largest 10 holders included MPM BioImpact LLC, Blue Owl Capital Holdings LP, FRANKLIN RESOURCES INC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, BRAIDWELL LP, AMERICAN INTERNATIONAL GROUP, INC., Nextech Invest Ltd., and CITADEL ADVISORS LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.